Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes
Autor: | Bram Brouwers, Matthijs K. C. Hesselink, Michael Roden, Dennis Dahlmans, Patrick Schrauwen, Tomas Jelenik, Anne Gemmink, Bas Havekes, Yvonne M. H. Bruls, Vera B. Schrauwen-Hinderling |
---|---|
Přispěvatelé: | Promovendi NTM, RS: NUTRIM - R1 - Obesity, diabetes and cardiovascular health, RS: NUTRIM - HB/BW section B, MUMC+: DA BV Klinisch Fysicus (9), RS: NUTRIM - R1 - Metabolic Syndrome, Interne Geneeskunde, MUMC+: MA Endocrinologie (9), Beeldvorming |
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
Adult
Male medicine.medical_specialty Magnetic Resonance Spectroscopy endocrine system diseases GLUCOSE-PRODUCTION Glucose uptake 030209 endocrinology & metabolism Type 2 diabetes Biology DISEASE 03 medical and health sciences 0302 clinical medicine Insulin resistance Non-alcoholic Fatty Liver Disease Internal medicine medicine Humans Insulin Aerobic exercise In patient Risk factor HEPATIC STEATOSIS Muscle Skeletal Aged Fatty liver nutritional and metabolic diseases Non alcoholic General Medicine NATURAL-HISTORY Middle Aged MAGNETIC-RESONANCE-SPECTROSCOPY Lipid Metabolism medicine.disease PREVALENCE Endocrinology TISSUE INSULIN-RESISTANCE Adipose Tissue Diabetes Mellitus Type 2 Liver INTRAHEPATIC TRIGLYCERIDE CONTENT Body Composition Glucose Clamp Technique SKELETAL-MUSCLE 030211 gastroenterology & hepatology Insulin Resistance SENSITIVITY |
Zdroj: | Clinical Science, 131(15), 1905-1917. Portland Press Ltd. |
ISSN: | 0143-5221 |
DOI: | 10.1042/cs20170261 |
Popis: | Non-alcoholic fatty liver (NAFL) is an independent risk factor for the development of type 2 diabetes (T2DM). We examined metabolic perturbations in patients with NAFL, patients with T2DM, and control (CON) subjects with normal intrahepatic lipid (IHL) content. A two-step (10 mU/m2 /min; 40 mU/m2/min) hyperinsulinemic–euglycemic clamp was performed in 11 NAFL, 13 T2DM, and 11 CON subjects, all matched for BMI, and aerobic fitness. IHL content was measured using proton magnetic resonance spectroscopy. Because of high IHL content variability in T2DM patients, this group was separated into a high IHL content group (IHL ≥ 5.0%, T2DM+NAFL) and a normal IHL content group (IHL < 5.0%, T2DM-non-NAFL) for further analysis. IHL content was increased in NAFL and T2DM+NAFL subjects (P0.05), and was lower in comparison with CON subjects (all P Individuals with NAFL suffer from metabolic perturbations to a similar degree as T2DM patients. NAFL is an important feature leading to severe insulin resistance and should be viewed as a serious health threat for the development of T2DM. ClinicalTrials.gov: NCT01317576 |
Databáze: | OpenAIRE |
Externí odkaz: |